Jaana Oikkonen

1.3k total citations
29 papers, 497 citations indexed

About

Jaana Oikkonen is a scholar working on Molecular Biology, Cognitive Neuroscience and Cancer Research. According to data from OpenAlex, Jaana Oikkonen has authored 29 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cognitive Neuroscience and 8 papers in Cancer Research. Recurrent topics in Jaana Oikkonen's work include Cancer Genomics and Diagnostics (8 papers), Neuroscience and Music Perception (7 papers) and Single-cell and spatial transcriptomics (6 papers). Jaana Oikkonen is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Neuroscience and Music Perception (7 papers) and Single-cell and spatial transcriptomics (6 papers). Jaana Oikkonen collaborates with scholars based in Finland, United States and Denmark. Jaana Oikkonen's co-authors include Irma Järvelä, Liisa Ukkola‐Vuoti, Kai Karma, Pirre Raijas, Päivi Onkamo, Chakravarthi Kanduri, Sampsa Hautaniemi, Johanna Hynninen, Sakari Hietanen and Kaisa Huhtinen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Jaana Oikkonen

27 papers receiving 482 citations

Peers

Countries citing papers authored by Jaana Oikkonen

Since Specialization

Citations

This map shows the geographic impact of Jaana Oikkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaana Oikkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaana Oikkonen more than expected).

Fields of papers citing papers by Jaana Oikkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaana Oikkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaana Oikkonen. The network helps show where Jaana Oikkonen may publish in the future.

Co-authorship network of co-authors of Jaana Oikkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Jaana Oikkonen. A scholar is included among the top collaborators of Jaana Oikkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaana Oikkonen. Jaana Oikkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit 2024 ·GigaScience ·(unknown), Jaana Oikkonen, (unknown), Taru Muranen, (unknown), (unknown), Alexandra Lahtinen, Kaisa Huhtinen, Rainer Lehtonen, Sakari Hietanen, Johanna Hynninen, Anni Virtanen, Sampsa Hautaniemi	2
2	High-level Biomedical Data Integration in a Semantic Knowledge Graph with OncodashKB for finding Personalized Actionable Drugs in Ovarian Cancer 2024 ·SPIRE - Sciences Po Institutional REpository ·Johann Dréo, Sebastian Lobentanzer, (unknown), (unknown), (unknown), Taru Muranen, Jaana Oikkonen, Federico Bolelli, (unknown), Veli‐Matti Isoviita, Johanna Hynninen, Benno Schwikowski	1
3	PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures 2024 ·Neoplasia ·(unknown), Alejandra Cervera, Vanina D. Heuser, Gun West, Jaana Oikkonen, (unknown), (unknown), Elisa Ficarra, Pekka Taimen, Johanna Hynninen, Rainer Lehtonen, Sampsa Hautaniemi, Olli Carpén, Kaisa Huhtinen	1
4	Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma 2024 ·BMC Cancer ·Sanaz Jamalzadeh, Jun Dai, (unknown), Yilin Li, Jing Jiang, Kaisa Huhtinen, Anni Virtanen, Jaana Oikkonen, Sakari Hietanen, Johanna Hynninen, Anna Vähärautio, Antti Häkkinen, Sampsa Hautaniemi	2
5	Abstract 4249: Establishment and analysis of patient-derived high-grade serous ovarian cancer organoids for disease modeling and drug testing 2024 ·Cancer Research ·Tuula Kallunki, (unknown), (unknown), Alexandra Lahtinen, Marie Lund Bay, (unknown), Kaisa Huhtinen, Taru Muranen, Jaana Oikkonen, Johanna Hynninen, Sampsa Hautaniemi	0
6	Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence 2023 ·Translational Oncology ·(unknown), (unknown), Mai Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen	3
7	Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma 2023 ·Biomedicine & Pharmacotherapy ·Mai Nguyen, (unknown), Kaisa Huhtinen, Sakari Hietanen, Johanna Hynninen, Jaana Oikkonen, Sampsa Hautaniemi	2
8	HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma 2023 ·Gynecologic Oncology ·(unknown), Yilin Li, (unknown), Taru Muranen, Veli‐Matti Isoviita, Kaisa Huhtinen, (unknown), (unknown), (unknown), Sakari Hietanen, Anni Virtanen, Sampsa Hautaniemi, Jaana Oikkonen, Johanna Hynninen	1
9	776P Multi-omics analysis of chemo-refractory high-grade serous carcinoma patients: Insights from the DECIDER study 2023 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexandra Lahtinen, (unknown), (unknown), Yingchun Li, (unknown), Jaana Oikkonen, (unknown), Kaisa Huhtinen, Sakari Hietanen, Anni Virtanen, Johanna Hynninen, Sampsa Hautaniemi	1
10	Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status 2022 ·Frontiers in Oncology ·(unknown), (unknown), Vanina D. Heuser, Swapnil Potdar, (unknown), Jaana Oikkonen, Yilin Li, (unknown), Krister Wennerberg, Johanna Hynninen, Seija Grénman, Kaisa Huhtinen, Annika Auranen, Olli Carpén, Katja Kaipio	11
11	QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability 2022 ·Laboratory Investigation ·Sanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, Kaisa Huhtinen, Anna Laury, Sakari Hietanen, Johanna Hynninen, Jaana Oikkonen, Olli Carpén, Anni Virtanen, Sampsa Hautaniemi	12
12	Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1 -Deficient Cells 2021 ·Cancer Research ·Anniina Färkkilä, Alfredo Rodríguez, Jaana Oikkonen, D. Gulhan, Huy Nguyen, (unknown), (unknown), Caitlin E. Mills, Fernando Pérez‐Villatoro, Jean‐Bernard Lazaro, Jia Zhou, Connor S. Clairmont, Lisa A. Moreau, Peter J. Park, Peter K. Sorger, Sampsa Hautaniemi, Sara Frı́as, Alan D. D’Andrea	19
13	Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer 2021 ·Briefings in Bioinformatics ·Liye He, Daria Bulanova, Jaana Oikkonen, Antti Häkkinen, Kaiyang Zhang, Shuyu Zheng, Wenyu Wang, Erdoğan Pekcan Erkan, Olli Carpén, (unknown), Sakari Hietanen, Johanna Hynninen, Kaisa Huhtinen, Sampsa Hautaniemi, Anna Vähärautio, Jing Tang, Krister Wennerberg, Tero Aittokallio	16
14	Detecting signatures of positive selection associated with musical aptitude in the human genome 2016 ·Scientific Reports ·Xuanyao Liu, Chakravarthi Kanduri, Jaana Oikkonen, Kai Karma, Pirre Raijas, Liisa Ukkola‐Vuoti, Yik‐Ying Teo, Irma Järvelä	20
15	Convergent evidence for the molecular basis of musical traits 2016 ·Scientific Reports ·Jaana Oikkonen, Päivi Onkamo, Irma Järvelä, Chakravarthi Kanduri	28
16	Creative Activities in Music – A Genome-Wide Linkage Analysis 2016 ·PLoS ONE ·Jaana Oikkonen, (unknown), P. Peltonen, Pirre Raijas, Liisa Ukkola‐Vuoti, Kai Karma, Päivi Onkamo, Irma Järvelä	18
17	Genome-Wide Copy Number Variation Analysis in Extended Families and Unrelated Individuals Characterized for Musical Aptitude and Creativity in Music 2013 ·PLoS ONE ·Liisa Ukkola‐Vuoti, Chakravarthi Kanduri, Jaana Oikkonen, Gemma Buck, Christine Blancher, Pirre Raijas, Kai Karma, Harri Lähdesmäki, Irma Järvelä	70
18	The genome-wide landscape of copy number variations in the MUSGEN study provides evidence for a founder effect in the isolated Finnish population 2013 ·European Journal of Human Genetics ·Chakravarthi Kanduri, Liisa Ukkola‐Vuoti, Jaana Oikkonen, Gemma Buck, Christine Blancher, Pirre Raijas, Kai Karma, Harri Lähdesmäki, Irma Järvelä	12
19	Correlation between components of newly diagnosed exudative age‐related macular degeneration lesion and focal retinal sensitivity 2012 ·Acta Ophthalmologica ·(unknown), Jaana Oikkonen, Päivi Onkamo, Ilkka Immonen	7
20	Association of the arginine vasopressin receptor 1A (AVPR1A) haplotypes with listening to music 2011 ·Journal of Human Genetics ·Liisa Ukkola‐Vuoti, Jaana Oikkonen, Päivi Onkamo, Kai Karma, Pirre Raijas, Irma Järvelä	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact